Antidote

APRIL 4, 2024

Before it is released onto the market, the development of any new drug or medical device must undergo rigorous testing , part of which involves clinical trials. Clinical trials are integral to making sure that any new therapy is both safe and effective for individuals, and volunteers are a vital part of the process.

Clinical Trials 119

Clinical Trials Clinical Trials Trials Marketing 119

World of DTC Marketing

APRIL 20, 2022

We just finished talking to over 200 hundred HCPs about pharma marketing and salespeople to measure any differences since before the pandemic. Attitudes are indeed changing, but one need remains clear: access to data obtained during clinical and ongoing trials. Will they transform their HCP marketing or stick to dated models?

Marketing 218

Marketing Drug Trials Drugs Sales 218

Fierce Pharma

APRIL 4, 2024

Amylyx Pharmaceuticals is keeping a promise by pulling the amyotrophic lateral sclerosis (ALS) therapy Relyvrio off the market after the drug failed in a confirmatory trial. Amylyx is keeping a promise by pulling the amyotrophic lateral sclerosis (ALS) therapy Relyvrio off the market after the drug failed in a confirmatory trial.

Marketing 117

Marketing Drugs Trials 117

AuroBlog - Aurous Healthcare Clinical Trials blog

MAY 3, 2023

Pharmaceutical giant Eli Lilly said Thursday it will seek approval to add its diabetes drug to the buzzy US weight loss market after achieving promising results in a new clinical trial. Tirzepatide, currently approved to treat type 2 diabetes under the name Mounjaro, is taken once a week as an injection. Eli Lilly said its […]

Clinical Trials 188

Clinical Trials Clinical Trials Trials Drugs 188

Pharmaceutical Technology

APRIL 13, 2023

Takeda’s announcement underlines the risk associated with gene therapy R&D at the preclinical stage and the fact that many current AAV programs are unlikely to reach late-stage trials.

Gene Therapy 243

Gene Therapy Marketing Gene In-Vivo 243

Fierce Pharma

SEPTEMBER 21, 2023

Six months after Travere Therapeutics’ Filspari won an accelerated nod to treat patients with a rare kidney disease, the first-of-its-kind drug narrowly failed its confirmatory trial. |

Trials 104

Trials Marketing FDA Approval Drugs 104

Bio Pharma Dive

MARCH 3, 2022

As Aduhelm sputters on the market, Roche aims to prove its experimental medicine can work better. A large, multi-year trial is part of that bet.

Trials 298

Trials Medicine Drugs Marketing 298

BioSpace

NOVEMBER 21, 2022

market while continuing to push other combination trial programs. ???????Following a request from the FDA, GSK is withdrawing its multiple myeloma drug Blenrep from the U.S.

Marketing 96

Marketing Trials Drugs 96

Pharmaceutical Technology

MAY 26, 2023

The immuno-oncology market continues to evolve as treatments establish their presence across different types of cancer, having seen approvals in multiple indications in the past decade. There are currently over 700 immuno-oncology products in Phase I-III of development in the eight major markets, said Chalk.

Marketing 264

Marketing Vaccination Vaccine Development 264

Pharmaceutical Technology

JUNE 15, 2023

Eloxx has revealed its lead candidate ELX-02 improved predicted forced expiratory volume (ppFEV1) in patients with Class 1 cystic fibrosis (CF) in a new analysis of a Phase II trial that missed its efficacy endpoints. The market responded warmly to the reanalysis. The regimen in the trial was a one-week monotherapy period (1.5

Trials 246

Trials Genetics Protein Marketing 246

Pharmaceutical Technology

SEPTEMBER 18, 2023

Experts say a wider diverse pool of patients needs to be given a chance to participate in clinical trials to get rare disease drugs faster to market.

Clinical Trials 162

Clinical Trials Clinical Trials Trials Marketing 162

pharmaphorum

NOVEMBER 22, 2022

GSK confirmed this morning that the disappointing readout from the DREAMM-3 trial of multiple myeloma therapy Blenrep reported earlier this month means that it will take the drug off the US market. The post GSK will pull Blenrep from US market after failed trial appeared first on.

Marketing 105

Marketing Trials Antibody Clinical Trials 105

Pharmaceutical Technology

OCTOBER 31, 2022

After decades of setbacks, the respiratory syncytial virus (RSV) vaccine field has bounced back with positive Phase III trial results in older adults. However, recent data from GSK’s sub-unit vaccine, GSK-3844766A, have pushed the candidate to the top, with the highest efficacy demonstrated in a pivotal trial to date.

Vaccination 338

Vaccination Vaccine Marketing Trials 338

Pharma Mirror

MAY 7, 2021

The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner, Avance Clinical, has expanded its gene technology clinical trial services to meet the increasing global demand predicted to reach $17.4 The post Avance Clinical Expands Gene Technology Clinical Trial Services to Meet $17.4

Clinical Trials 130

Clinical Trials Clinical Trials Gene Marketing 130

Pharmaceutical Technology

JULY 6, 2022

Talks of a bear market in the biotech sector do not seem to pass, with news of companies falling into administration and layoffs becoming a recurrence. Just last week, trading for 4D Pharma , a British biotech, was suspended on the London Stock Exchange’s Alternative Investment Market , and the company will be delisted from NASDAQ on July 7.

Marketing 324

Marketing Gene Therapy Manufacturing Pharma Companies 324

Pharmaceutical Technology

MAY 22, 2023

The European Medicines Agency (EMA) has accepted and verified Sobi’s marketing authorisation application for a new factor VIII (FVIII), efanesoctocog alfa, to treat haemophilia A patients of all ages. In February 2023, the US Food and Drug Administration approved efanesoctocog alfa as ALTUVIIIO.

Marketing 217

Marketing Genetics Trials Medicine 217

Bio Pharma Dive

NOVEMBER 27, 2023

market because of negative data, new study results might crack open the door to a relaunch. One year after the U.K. drugmaker withdrew the multiple myeloma drug from the U.S.

Drugs 268

Drugs Trials Marketing 268

Bio Pharma Dive

APRIL 4, 2024

In the wake of a major trial failure, the company is withdrawing Relyvrio and cutting costs with a restructuring that involves laying off 70% of its employees.

Marketing 165

Marketing Drugs Trials 165

Worldwide Clinical Trials

FEBRUARY 26, 2024

With the necessary prioritization of various factors when designing your clinical trial, the patient experience can be overlooked or improperly addressed in study design. It plays a significant role in patient recruitment and retention, both of which are vital to maintaining timelines, decreasing program costs, and gaining market approval.

Clinical Trials 138

Clinical Trials Clinical Trials Trials Clinical Research 138

Drug Discovery World

OCTOBER 20, 2023

A new free service will offer insights in under ten days to sponsors conducting clinical trials, identifying potential ‘zombie trials’ and providing actionable recommendations for failing trials. The Health Check and Trial Rescue Service is an initiative of data software and services company Phesi.

Clinical Trials 62

Clinical Trials Clinical Trials Trials Marketing 62

Pharmaceutical Technology

JUNE 7, 2023

The European Commission (EC) has granted marketing authorisation for Fennec Pharmaceuticals’ Pedmarqsi (sodium thiosulfate) to reduce the risk of hearing loss in paediatric oncology patients.

Marketing 130

Marketing Medicine Trials Production 130

Fierce Pharma

NOVEMBER 15, 2023

In response to an onslaught from Eli Lilly, Novo Nordisk is escalating the obesity market battle with a new head-to-head trial against its archrival. | In response to an onslaught from Eli Lilly, Novo Nordisk is escalating the obesity market battle with a new head-to-head trial against its archrival.

Trials 144

Trials Marketing 144

Pharmaceutical Technology

APRIL 24, 2023

Apellis Pharmaceuticals has received validation of its four marketing applications for intravitreal pegcetacoplan by regulatory authorities in Switzerland, the UK, Canada and Australia. The marketing applications are based on the data obtained from the Phase III OAKS and DERBY trials at 24 months.

Marketing 130

Marketing Trials Regulation Development 130

Pharmaceutical Technology

FEBRUARY 23, 2023

The market for UC is filled with various treatment options, and the pipeline is relatively strong. These novel agents are expected to strengthen the market by bringing more innovation to the space. Pivotal data is expected around May next year with the maintenance trial expected to read out in June 2025.

Marketing 147

Marketing Trials Compliance Development 147

AuroBlog - Aurous Healthcare Clinical Trials blog

MARCH 6, 2023

The expert committee which advises the drug regulator on clinical trials and drug approvals has recommended for grant of permission for import and marketing of Swiss multinational pharma major Roche’s ophthalmic drug faricimab intravitreal injection in India, with waiver of local phase III clinical trial subject to conditions.

Trials 153

Trials Clinical Trials Clinical Trials Drugs 153

Fierce Pharma

NOVEMBER 27, 2023

After a positive trial readout, GSK sure hopes so. | After a positive trial readout for the BCMA-targeted antibody-drug conjugate, GSK sure hopes so. Is Blenrep back from the dead? Is Blenrep back from the dead?

Trials 91

Trials Marketing Antibody Drugs 91

pharmaphorum

JANUARY 11, 2024

Generative AI is revolutionising the pharmaceutical industry, accelerating the speed to market for new drugs. Learn how regulatory processes, R&D, and clinical trials are being impacted by this innovative technology.

Marketing 122

Marketing Clinical Trials Clinical Trials Trials 122

World of DTC Marketing

FEBRUARY 15, 2022

Biotechs need to think like marketers to cut through the noise and attract investors. CEOs have to think like marketers to cut through the clutter with all the biotech startups out there. 2wo: Clinical trial data releases need to coincide with major medical conferences.

Marketing 224

Marketing Clinical Trials Clinical Trials Trials 224

Antidote

SEPTEMBER 25, 2023

Clinical trials are how researchers advance their knowledge about potential new treatments, including medications, medical devices, and lifestyle interventions. Clinical trials are divided into phases , each with a distinct duration, purpose, and number of volunteers needed.

Clinical Trials 128

Clinical Trials Clinical Trials Trials Marketing 128

Pharmaceutical Technology

JULY 29, 2022

According to GlobalData’s Epidemiology and Market Size database, epidemiologists estimate there are more than 21 million prevalent cases within the tracked 16 countries. Last year saw the most with 167 trials. Cerevel Therapeutics has two Phase II/III trials and three Phase III trials planned.

Trials 246

Trials Drugs Clinical Trials Clinical Trials 246

ProRelix Research

NOVEMBER 2, 2023

Although clinical trials provide useful information regarding the efficacy and safety of new drugs, biological products, and medical devices, the information captured through them is not all-encompassing. Limited patient populations, […] The post Post-Marketing Surveillance Strategies appeared first on ProRelix Research.

Marketing 98

Marketing Clinical Trials Clinical Trials Production 98

Pharmaceutical Technology

AUGUST 7, 2023

Following the publication of Phase II trial results and marketing approval in China, Akeso has started five Phase III trials.

Trials 130

Trials Marketing 130

Pharmaceutical Technology

JULY 7, 2023

The EMA has granted Novavax’s Covid-19 vaccine a full marketing authorisation, based on Phase III trial data.

Vaccination 130

Vaccination Vaccine Marketing Trials 130

Pharmaceutical Technology

DECEMBER 6, 2023

The clinical trial market is in a state of flux; to navigate it, supply chain optimisation will be essential.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Marketing 130

Pharmaceutical Technology

DECEMBER 9, 2022

The European Commission (EC) has granted marketing authorisation for Takeda ’s Qdenga (Dengue Tetravalent Vaccine [Live, Attenuated]) (TAK-003) to prevent dengue in people aged four years and above. The approval in the European Union (EU) was backed by data from 19 Phase I, II, and III clinical trials in over 28,000 children and adults.

Vaccination 147

Vaccination Vaccine Marketing Trials 147

Pharmaceutical Technology

MARCH 28, 2024

Boundless has two assets in clinical trials targeting extrachromosomal DNA in cancer patients.

DNA 147

DNA Clinical Trials Clinical Trials Marketing 147

Bio Pharma Dive

AUGUST 17, 2022

Trial results position the company to seek approval for indolent systemic mastocytosis, which executives have painted as a “multibillion dollar” market opportunity. Even so, shares fell by double digits in trading Wednesday.

Marketing 165

Marketing Drugs Trials 165